We applied T2/T1-weighted MRI together with behavior, Hematoxylin&Eosin（HE）and immunohistochemistry fluorescence staining (IHC) to evaluate the role of microglial SMAD7, a novel therapeutic approach, in a TBI mouse model. The consistency between MRI results and behavior and myelin and neurnal marker outcomes suggest that the protective role of over-expression of microglial SMAD7 in TBI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords